Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Co-Diagnostics, Inc. - Common Stock (NQ:CODX)

1.260 UNCHANGED
Streaming Delayed Price Updated: 4:15 PM EDT, Oct 27, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Co-Diagnostics, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 Next >
Co-Diagnostics CODX Earnings Call Transcript
Via The Motley Fool
Topics Earnings
CO-Diagnostics Inc (NASDAQ:CODX) Reports Mixed Q2 2025 Earnings with Revenue Beat but Persistent Losses
Co-Diagnostics (CODX) Q2 2025 earnings show revenue beat at $160K but EPS loss of -$0.23. Shares flat post-report as investors await profitability signs. 
Via Chartmill
Co-Diagnostics Sales Plunge 93 Percent
Via The Motley Fool
Earnings Scheduled For August 14, 2025
 
Via Benzinga
12 Health Care Stocks Moving In Tuesday's After-Market Session
 
Via Benzinga
Earnings Scheduled For May 8, 2025
 
Via Benzinga
Examining the Future: Co-Diagnostics's Earnings Outlook
 
Via Benzinga
Uncovering Potential: Co-Diagnostics's Earnings Preview
 
Via Benzinga
Peering Into Co-Diagnostics's Recent Short Interest
 
Via Benzinga
Thursday's pre-market session: top gainers and losers
The US market session of Thursday has yet to be opened, let's have a look at the top gainers and losers in the pre-market session today. 
Via Chartmill
12 Health Care Stocks Moving In Thursday's Pre-Market Session
 
Via Benzinga
Stay updated with the stocks that are on the move in today's pre-market session.
Discover the top movers in Friday's pre-market session and stay informed about market dynamics. 
Via Chartmill
Co-Diagnostics: Q4 Earnings Insights
 
Via Benzinga
Earnings Preview: Co-Diagnostics
 
Via Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session
 
Via Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session
 
Via Benzinga
These stocks are moving in today's after hours session
As the regular session of the US market on Monday comes to an end, let's delve into the after-hours session and discover the top gainers and losers shaping the post-market sentiment. 
Via Chartmill
This Kohl's Analyst Begins Coverage On A Bearish Note; Here Are Top 5 Initiations For Monday
 
Via Benzinga
12 Health Care Stocks Moving In Tuesday's After-Market Session
 
Via Benzinga
Earnings Scheduled For March 27, 2025
 
Via Benzinga
Top movers in Tuesday's after hours session
Wondering what's happening in today's after-hours session? Stay tuned for the latest updates on stock movements. 
Via Chartmill
Penny Stock Co-Diagnostics Withdraws FDA Application For COVID-19 Test, Plans To Submit Enhanced Version
Co-Diagnostics plans to submit an enhanced COVID-19 test for FDA clearance, addressing stability concerns and integrating platform advancements. 
Via Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
 
Via Benzinga
CODX Stock Earnings: Co-Diagnostics Beats EPS, Beats Revenue for Q2 2024
CODX stock results show that Co-Diagnostics beat analyst estimates for earnings per share and beat on revenue for the second quarter of 2024. 
Via InvestorPlace
12 Health Care Stocks Moving In Monday's Pre-Market Session
 
Via Benzinga
Why G-III Apparel Shares Are Trading Lower By 13%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
 
Via Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
 
Via Benzinga
CODX Stock Earnings: Co-Diagnostics Misses EPS, Misses Revenue for Q1 2024
CODX stock results show that Co-Diagnostics missed analyst estimates for earnings per share and missed on revenue for the first quarter of 2024. 
Via InvestorPlace
CODX Stock Earnings: Co-Diagnostics Misses EPS, Misses Revenue for Q4 2023
CODX stock results show that Co-Diagnostics missed analyst estimates for earnings per share and missed on revenue for the fourth quarter of 2023. 
Via InvestorPlace
Earnings Scheduled For March 14, 2024
Companies Reporting Before The Bell • Pharming (NASDAQ:PHAR) is projected to report earnings for its fourth quarter. 
Via Benzinga
< Previous 1 2 3 4 5 6 7 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.